There may be two distinct subtypes of multiple sclerosis, according to a new study led by scientists at University College ...

Quantum Biopharma expects data from two now-completed, FDA-requested toxicology studies to support clinical testing of its ...

A genome-wide association study (GWAS) including more than 22,000 people with multiple sclerosis (MS) has uncovered the first genetic variant associated with faster progression of the autoimmune ...

—Genetic loci that are associated with disability in multiple sclerosis have been identified as contributing to its progression, showing that the central nervous system, not the immune system, ...

Researchers have identified the first genetic marker of multiple sclerosis severity. The genetic variant was seen in people who experienced quicker progression of the disease, resulting in greater ...

“We knew that genetics is important for risk, but this variability of outcome suggested that genetics may also play a role in severity.” Dr. Baranzini and his team utilized data from two large MS ...

Multiple sclerosis (MS) is a chronic disease in which the myelin sheath, an insulation that surrounds nerve cells, is slowly destroyed. The causes of the disorder are unclear, but it's thought to be ...

A study of more than 22,000 people with multiple sclerosis (MS) has for the first time identified a genetic variant associated with faster progression of the disease, an accumulation of disability ...

Prof Nicholas Schwab and his colleagues found a biomarker which allows to tell in advance if therapy with glatirameracetate will be efficient in an individual MS patent. Treatment with interferon or ...

Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs. Note: Hover over the donut graph to view ...